Certain Blood Types Could Be Associated with Greater Risk of Contracting COVID-19, Confirms New Study
|
By HospiMedica International staff writers Posted on 04 Mar 2021 |

Illustration
As researchers around the world work to identify and address risk factors for severe COVID-19, there is additional evidence that certain blood types could be associated with greater risk of contracting the disease.
The findings of one of the first laboratory studies conducted by researchers at Brigham and Women’s Hospital (Boston, MA, USA) suggest that SARS-CoV-2, the virus that causes COVID-19, is particularly attracted to the blood group A antigen found on respiratory cells. In the study, researchers assessed a protein on the surface of the SARS-CoV-2 virus called the receptor binding domain, or RBD. The RBD is the part of the virus that attaches to the host cells, so it is an important research target for understanding how infection occurs. The team assessed synthetic blood group antigens on respiratory and red blood cells found in blood group A, B, and O individuals, and analyzed how the SARS-CoV-2 RBD interacted with each unique blood type. They discovered that the RBD had a strong preference for binding to blood group A found on respiratory cells. It did not display a preference for blood group A red blood cells, or other blood groups found on respiratory or red cells. The capacity of the RBD to preferentially recognize and attach to the blood type A antigen found in the lungs of blood type A individuals may provide insight into the potential link between blood group A and COVID-19 infection.
Based on their observations, the team sought to determine whether a similar binding preference existed for the RBD of SARS-CoV, the virus that causes severe acute respiratory syndrome (SARS). Although the makeup of the virus differs, the SARS-CoV RBD exhibited the same preference to bind to the group A antigens on respiratory cells. The team has emphasized that their findings alone could not fully describe or predict how coronaviruses like SARS-CoV-2 and SARS-CoV would affect patients of various blood types. While further research is needed to understand that influence, the research adds to findings from earlier studies suggesting a possible link between blood type and COVID-19 susceptibility and severity.
“It is interesting that the viral RBD only really prefers the type of blood group A antigens that are on respiratory cells, which are presumably how the virus is entering most patients and infecting them,” said study author Sean R. Stowell, MD, PhD, of Brigham and Women’s Hospital. “Blood type is a challenge because it is inherited and not something we can change. But if we can better understand how the virus interacts with blood groups in people, we may be able to find new medicines or methods of prevention.”
Related Links:
Brigham and Women’s Hospital
The findings of one of the first laboratory studies conducted by researchers at Brigham and Women’s Hospital (Boston, MA, USA) suggest that SARS-CoV-2, the virus that causes COVID-19, is particularly attracted to the blood group A antigen found on respiratory cells. In the study, researchers assessed a protein on the surface of the SARS-CoV-2 virus called the receptor binding domain, or RBD. The RBD is the part of the virus that attaches to the host cells, so it is an important research target for understanding how infection occurs. The team assessed synthetic blood group antigens on respiratory and red blood cells found in blood group A, B, and O individuals, and analyzed how the SARS-CoV-2 RBD interacted with each unique blood type. They discovered that the RBD had a strong preference for binding to blood group A found on respiratory cells. It did not display a preference for blood group A red blood cells, or other blood groups found on respiratory or red cells. The capacity of the RBD to preferentially recognize and attach to the blood type A antigen found in the lungs of blood type A individuals may provide insight into the potential link between blood group A and COVID-19 infection.
Based on their observations, the team sought to determine whether a similar binding preference existed for the RBD of SARS-CoV, the virus that causes severe acute respiratory syndrome (SARS). Although the makeup of the virus differs, the SARS-CoV RBD exhibited the same preference to bind to the group A antigens on respiratory cells. The team has emphasized that their findings alone could not fully describe or predict how coronaviruses like SARS-CoV-2 and SARS-CoV would affect patients of various blood types. While further research is needed to understand that influence, the research adds to findings from earlier studies suggesting a possible link between blood type and COVID-19 susceptibility and severity.
“It is interesting that the viral RBD only really prefers the type of blood group A antigens that are on respiratory cells, which are presumably how the virus is entering most patients and infecting them,” said study author Sean R. Stowell, MD, PhD, of Brigham and Women’s Hospital. “Blood type is a challenge because it is inherited and not something we can change. But if we can better understand how the virus interacts with blood groups in people, we may be able to find new medicines or methods of prevention.”
Related Links:
Brigham and Women’s Hospital
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Artificial Intelligence
view channel
Predictive Model Supports Growth Hormone Treatment Planning in Idiopathic Short Stature
Idiopathic short stature (ISS) describes children whose height is substantially below the expected range for age and sex without an identifiable medical cause. Recombinant growth hormone therapy can support... Read more
AI Model Predicts Prolonged Sitting in Chronic Pelvic Pain
Chronic pelvic pain affects an estimated one in seven women and can occur with conditions such as endometriosis, adenomyosis, or uterine fibroids. Pain, fatigue, and other symptoms may contribute to prolonged... Read moreCritical Care
view channel
Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery
Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more
AI Tool Combining ECG and Blood Tests Reduces Unnecessary Heart Transplant Biopsies
Cardiac transplant rejection occurs when a recipient’s immune system attacks a donated heart. Diagnosis currently relies on biopsy, an invasive procedure in which heart muscle tissue is removed and examined... Read more
Deep Brain Stimulation Window May Matter for Parkinson’s Patients With GBA1 Variants
Patients with GBA1 gene variants may develop significant physical symptoms earlier in life while also facing greater vulnerability to cognitive problems. This combination can complicate decisions about... Read moreFDA-Approved App Enables Pulmonary Pressure Monitoring and Medication Guidance in Heart Failure
Heart failure is a chronic, progressive condition and a leading cause of hospitalization, with clinical status often deteriorating before symptoms appear. Rising pulmonary artery pressure can precede decompensation... Read moreSurgical Techniques
view channel
FDA Clears Antibiotic-Delivering Spacer for Infected Knee Replacements
Periprosthetic joint infection develops around an artificial joint implant and can be especially difficult to manage after knee replacement. Treatment may require removal of the implant, prolonged infection... Read more
Matrix-Based Skin Substitute Improves Closure of Diabetic Foot Ulcers
Diabetic foot ulcers are hard-to-heal wounds that can persist because of chronic inflammation and moisture imbalance. When standard care alone does not achieve timely closure, clinicians may use adjunctive... Read morePatient Care
view channel
AI Platform Personalizes Support Between Visits for Cancer Survivors
Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more
At-Home Neuromodulation Shows Promise in Selected Patients With Hypertension
High blood pressure is a major risk factor for cardiovascular disease, including heart attack and stroke. Many patients receiving treatment for hypertension still remain above recommended blood pressure... Read more
EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
Determining when patients with metastatic breast cancer are nearing the end of life remains difficult, often leading to intensive interventions with limited benefit. Prognostic uncertainty can delay goals-of-care... Read moreMedical Imaging
view channel
PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI
Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more
AI Software Detects Osteoporosis from Routine CT Scans
Osteoporosis can progress for years without pain, leaving bone loss undetected until a fracture or back pain prompts testing. By that point, bone loss may already be advanced. Bone density testing is not... Read more
AI Model Uses Pretreatment CT Scans to Predict Immunotherapy-Related Pneumonitis Risk
Pneumonitis is a potentially life-threatening form of lung inflammation that affects about 10% of patients with lung cancer receiving immunotherapy. Because it can be difficult to predict before symptoms... Read moreHealth IT
view channel
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read more
Adaptive Radiation QA Software Gains Validation for NeoArc Treatments
Adaptive radiation therapy allows clinicians to adjust treatment plans to daily anatomical changes such as tumor shrinkage, weight loss, or organ movement, improving precision while limiting exposure to... Read morePoint of Care
view channel
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read moreBusiness
view channelWorld Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition
World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery
As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Robotic Single-Port System Gains CE Mark for Transvaginal Gynecologic Procedures
Intuitive (Sunnyvale, CA, USA) announced that it has received CE mark approval for use of the da Vinci SP Single Port surgical system in transvaginal gynecologic procedures, marking the first such indication... Read more








